Abstract
3-(4-[(3-Chlorophenyl)methoxy]phenyl)-5-[(methylamino)methyl]-2- oxazolidinone methanesulphonate (compound MD 780236) is a selective inhibitor of the B-form of monoamine oxidase. Inhibition involves an initial non-covalent interaction between enzyme and inhibitor followed by a time-dependent process resulting in irreversible inhibition. The initial, reversible, phase of inhibition was found to be competitive with respect to phenethylamine and 5-hydroxytryptamine, and a comparison of the Ki values indicated the affinity of the inhibitor for the B-form of the enzyme to be some 7-fold greater than its affinity for the A-form. This selectivity was considerably enhanced by preincubation of the enzyme and inhibitor. Time courses showed that complete inhibition was not achieved under conditions where the inhibitor concentration was over 100-fold greater than that of the enzyme. Assay of the activity of monoamine oxidase by determining the release of hydrogen peroxide fluorometrically showed compound MD 780236 to be a substrate for, as well as an inhibitor of, monoamine oxidase, and kinetic analysis revealed that the rate of product formation was some 530-fold greater than that of the process leading to irreversible inhibition of the B-form of the enzyme.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
- Fowler C. J., Callingham B. A. The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers. Mol Pharmacol. 1979 Sep;16(2):546–555. [PubMed] [Google Scholar]
- Fowler C. J., Oreland L. The nature of the substrate-selective interaction between rat liver mitochondrial monoamine oxidase and oxygen. Biochem Pharmacol. 1980 Aug 15;29(16):2225–2233. doi: 10.1016/0006-2952(80)90202-6. [DOI] [PubMed] [Google Scholar]
- Fowler C. J., Tipton K. F. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Biochem Pharmacol. 1981 Dec 15;30(24):3329–3332. doi: 10.1016/0006-2952(81)90607-9. [DOI] [PubMed] [Google Scholar]
- Fowler C. J., Wiberg A., Oreland L., Winblad B. Titration of human brain type-B monoamine oxidase. Neurochem Res. 1980 Jul;5(7):697–708. doi: 10.1007/BF00964708. [DOI] [PubMed] [Google Scholar]
- Johnston J. P. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol. 1968 Jul;17(7):1285–1297. doi: 10.1016/0006-2952(68)90066-x. [DOI] [PubMed] [Google Scholar]
- Knoll J., Magyar K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol. 1972;5:393–408. [PubMed] [Google Scholar]
- Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
- O'Brien R. D. Kinetics of the carbamylation of cholinesterase. Mol Pharmacol. 1968 Mar;4(2):121–130. [PubMed] [Google Scholar]
- OTSUKA S., KOBAYASHI Y. RADIOISOTOPIC ASSAY FOR MONOAMINE OXIDASE DETERMINATIONS IN HUMAN PLASMA. Biochem Pharmacol. 1964 Jul;13:995–1006. doi: 10.1016/0006-2952(64)90096-6. [DOI] [PubMed] [Google Scholar]
- Tipton K. F. A sensitive fluorometric assay for monoamine oxidase. Anal Biochem. 1969 Apr 4;28(1):318–325. doi: 10.1016/0003-2697(69)90186-9. [DOI] [PubMed] [Google Scholar]
- Waley S. G. Kinetics of suicide substrates. Biochem J. 1980 Mar 1;185(3):771–773. doi: 10.1042/bj1850771. [DOI] [PMC free article] [PubMed] [Google Scholar]